Page 66 - Read Online

Page 10 of 10 Gonzaga-Jauregui et al. Rare Dis Orphan Drugs J 2024;3:16 https://dx.doi.org/10.20517/rdodj.2024.02

25. Gonzaga-Jauregui C. Chapter 13: challenges and opportunities in rare diseases. In: Gonzaga-Jauregui C, Lupski JR, editors. Genomics
of rare diseases: understanding disease genetics using genomic approaches. San Diego: Academic Press/Elsevier Inc., 2021, pp. 263-
84.
26. Cabello JF, Novoa F, Huff HV, Colombo M. Expanded newborn screening and genomic sequencing in Latin America and the resulting
social justice and ethical considerations. Int J Neonatal Screen 2021;7:6. DOI PubMed PMC
27. Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.
NPJ Genom Med 2018;3:10. DOI PubMed PMC
28. Chung CCY, Leung GKC, Mak CCY, et al. Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease
patients and reduces healthcare costs. Lancet Reg Health West Pac 2020;1:100001. DOI PubMed PMC
29. Dimmock D, Caylor S, Waldman B, et al. Project baby bear: rapid precision care incorporating rWGS in 5 California children’s
hospitals demonstrates improved clinical outcomes and reduced costs of care. Am J Hum Genet 2021;108:1231-8. DOI PubMed
PMC
30. Monies D, Goljan E, Assoum M, et al; Rapid Exome Consortium. The clinical utility of rapid exome sequencing in a consanguineous
population. Genome Med 2023;15:44. DOI